Log in

GPC Green Plus Joint Stock Company UPCOM · Vietnam

Green Plus Joint Stock (GPC) news

Green Plus Joint Stock Company is a public biotech or pharmaceutical company listed on UPCOM under the ticker GPC, recorded under Vietnam. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Green Plus Joint Stock news

We have not published a story on Green Plus Joint Stock yet. When there is news, it will appear here.

Questions about Green Plus Joint Stock

What is the ticker symbol of Green Plus Joint Stock?

Green Plus Joint Stock Company trades under the ticker GPC on UPCOM.

Where is Green Plus Joint Stock listed?

Green Plus Joint Stock Company is listed on UPCOM.

Which country or territory is Green Plus Joint Stock listed under?

Our directory records Green Plus Joint Stock Company under Vietnam.

What does Green Plus Joint Stock do?

Our directory classifies Green Plus Joint Stock Company as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Green Plus Joint Stock?

The ISIN recorded for Green Plus Joint Stock Company is VN000000GPC5.

Does aibio.space cover Green Plus Joint Stock?

aibio.space lists Green Plus Joint Stock Company among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Green Plus Joint Stock?

Companies in our directory listed in the same country and business area as Green Plus Joint Stock: Medipharco Pharmaceutical Joint Stock Co, Nam Ha Pharmaceutical Joint Stock, Vietnam Medicinal Materials Joint Stock, Central Pharmaceutical CPC1.JSC, Cuu Long Pharmaceutical JSC, Hai Duong Pharmaceutical Medical Material Joint Stock Co.

Investor discussion: Green Plus Joint Stock

Members talk about Green Plus Joint Stock (GPC). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Green Plus Joint Stock Company is a public biotech or pharmaceutical company listed on UPCOM under the ticker GPC, recorded under Vietnam. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Green Plus Joint Stock Company
Ticker
GPC
Listing
UPCOM
Country or territory
Vietnam
Business scope
Pharmaceuticals: Major
ISIN
VN000000GPC5
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.